(PFX) Phenixfin - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US71742W1036
PFX: Investment Management, Debt Financing, Equity Participation
PhenixFIN Corporation (NASDAQ:PFX) is a business development company (BDC) specializing in private debt and equity investments in small and middle-market companies across North America. The firm operates in a wide range of sectors, including business services, real estate, automotive, oil and gas, aerospace, defense, and consumer products. PhenixFIN targets companies with enterprise values or asset values between $25 million and $250 million, focusing on private debt transactions ranging from $10 million to $50 million. The firm typically holds investments for 3 to 7 years, often to maturity or repayment, but may exit earlier. PhenixFIN may take board seats in portfolio companies and provide managerial support. Its investment structures include senior and subordinated debt, unitranche loans, and warrants for equity participation. The company, founded in 2010 and headquartered in New York, may co-invest in select transactions.
From a technical perspective, PFX is currently trading at $53.35, with a 20-day average volume of 3,483 shares. The stock has recently crossed above its 20-day SMA of $50.44 and remains above its 50-day SMA of $49.02, signaling short-term bullish momentum. The 200-day SMA of $46.13 further supports the positive trend. The ATR of 1.03 indicates relatively low volatility.
Fundamentally, PhenixFIN has a market cap of $107.31 million, with a P/E ratio of 6.51 and a forward P/E of 14.25. The P/B ratio of 0.66 suggests undervaluation relative to book value. The P/S ratio of 4.73 reflects moderate revenue multiples. The RoE of 0.01 highlights the need for operational efficiency improvements.
Additional Sources for PFX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PFX Stock Overview
Market Cap in USD | 109m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2011-01-21 |
PFX Stock Ratings
Growth 5y | 86.3% |
Fundamental | 27.7% |
Dividend | 78.6% |
Rel. Strength | 3.09 |
Analysts | 3/5 |
Fair Price Momentum | 67.09 USD |
Fair Price DCF | 184.25 USD |
PFX Dividends
Dividend Yield 12m | 5.58% |
Yield on Cost 5y | 30.38% |
Annual Growth 5y | 121.22% |
Payout Consistency | 54.7% |
PFX Growth Ratios
Growth Correlation 3m | 72.5% |
Growth Correlation 12m | 92.2% |
Growth Correlation 5y | 75.2% |
CAGR 5y | 44.55% |
CAGR/Max DD 5y | 1.32 |
Sharpe Ratio 12m | -0.19 |
Alpha | 16.39 |
Beta | 0.875 |
Volatility | 29.36% |
Current Volume | 0.3k |
Average Volume 20d | 1k |
As of April 04, 2025, the stock is trading at USD 52.35 with a total of 312 shares traded.
Over the past week, the price has changed by -1.80%, over one month by -1.87%, over three months by +10.05% and over the past year by +26.33%.
Neither. Based on ValueRay Fundamental Analyses, Phenixfin is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 27.65 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PFX as of April 2025 is 67.09. This means that PFX is currently undervalued and has a potential upside of +28.16% (Margin of Safety).
Phenixfin has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold PFX.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PFX Phenixfin will be worth about 74.3 in April 2026. The stock is currently trading at 52.35. This means that the stock has a potential upside of +41.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 35 | -33.1% |
Analysts Target Price | 35 | -33.1% |
ValueRay Target Price | 74.3 | 41.9% |